➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Express Scripts
AstraZeneca
Moodys
Mallinckrodt

Last Updated: July 30, 2021

DrugPatentWatch Database Preview

Litigation Details for Endo Pharmaceuticals Inc., and Grunenthal GbmH v. Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc. (S.D.N.Y. 2012)


Email this page to a colleague

« Back to Dashboard

Endo Pharmaceuticals Inc., and Grunenthal GbmH v. Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc. (S.D.N.Y. 2012)

Docket ⤷  Free Forever Trial Date Filed 2012-11-05
Court District Court, S.D. New York Date Terminated 2016-06-29
Cause 35:145 Civil Action to Obtain Patent Assigned To James Paul Oetken
Jury Demand None Referred To Gabriel W. Gorenstein
Parties TEVA PHARMACEUTICAL INDUSTRIES LTD.
Patents 6,096,339; 6,294,195; 6,309,663; 6,340,475; 6,488,963; 6,562,375; 6,635,280; 6,699,503; 6,723,340; 6,733,783; 7,776,314; 7,851,482; 8,075,872; 8,114,383; 8,192,722; 8,309,060; 8,309,122; 8,329,216
Attorneys Sarah Emily Craven
Firms The Schulman Law Firm LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Endo Pharmaceuticals Inc., and Grunenthal GbmH v. Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc.

Details for Endo Pharmaceuticals Inc., and Grunenthal GbmH v. Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc. (S.D.N.Y. 2012)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 6,009,690 A 1/2000 nomng 6,077,538 A 6/2000 Merrill 6,096,339 A SIZUC)U Aycrcla.l. 6,117,4$3 A 9/2000 Set]:leta…5,968,925 6,001,391 6,009,390 6,009,690 6,077,533 6,096,339 6,1 17,453 6.120.802 6,133,241 6,228,363 6,235,825…482 Patent would constitute infringement of the patent COUNT II: INFRINGEMENT OF THE ’383 PATENT …383 Patent would constitute infringement of the patent COUNT III: lNFRINGEMENT OF THE ’722 PATENT 58…United States Patent (10_) Patent N_o.: US 8,192,722 BZ Arkenau-Maric et al. (45) Date of Patent: *Jun. 5, External link to document
2015-03-17 117 States Patent Number 8,114,383. Summary judgment is denied with regard to United States patent numbers…2012 29 June 2016 1:12-cv-08060 830 Patent None District Court, S.D. New External link to document
2015-03-17 148 Compare Claim 9, U.S. Patent No. 8,114,383 B2 with Claim 8, U.S. Patent No. 8,114,383 B2. Plaintiffs… three of the six patents in suit, U.S. Patent Numbers 8,114,383 (“the ’383 Patent”), 8,309,060 (“the…of the patents asserted in that case was United States Patent Number 8,114,383. Id. That patent, the ’…States Patent Number 8,114,383. Summary judgment is denied with regard to United States patent numbers…States Patent Number 8,114,383. Summary judgment is denied with regard to United States patent numbers External link to document
2015-03-27 152 STIPULATION AND ORDER REGARDING U.S. PATENT NO. 8,309,122 AND U.S. PATENT NO. 8,329,216: Endo and Defendants…2012 29 June 2016 1:12-cv-08060 830 Patent None District Court, S.D. New External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Moodys
Mallinckrodt
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.